Evidence map›Paper›PMID 35467263›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2022

Resistin Modulates Low-Density Lipoprotein Cholesterol Uptake in Human Placental Explants via PCSK9.

Sonia Nava-Salazar, Arturo Flores-Pliego, Giovanni Pérez-Martínez, Sandra Parra-Hernández, America Vanoye-Carlo, Francisco Ibarguengoitia-Ochoa, Otilia Perichart-Perera, Enrique Reyes-Muñoz, Juan Mario Solis-Paredes, Salvador Espino Y Sosa and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Alterations in infant adipokine concentrations in the first postnatal week with exposure to diabetes in pregnancy.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Role of Adipokines in Inflammatory Mechanisms of Obesity.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Sonia Nava-SalazarDepartment of Immunobiochemistry, Instituto Nacional de Perinatologia, Mexico City, Mexico.
Arturo Flores-PliegoDepartment of Immunobiochemistry, Instituto Nacional de Perinatologia, Mexico City, Mexico.
Giovanni Pérez-MartínezDepartment of Immunobiochemistry, Instituto Nacional de Perinatologia, Mexico City, Mexico.
Sandra Parra-HernándezDepartment of Immunobiochemistry, Instituto Nacional de Perinatologia, Mexico City, Mexico.
America Vanoye-CarloNeuroscience Laboratory, Instituto Nacional de Pediatría, Mexico City, Mexico.
Francisco Ibarguengoitia-OchoaDepartment of Obstetrics, Instituto Nacional de Perinatologia, Mexico City, Mexico.
Otilia Perichart-PereraDepartment of Nutrition and Bioprogramming, Instituto Nacional de Perinatologia, Mexico City, Mexico.
Enrique Reyes-MuñozCoordination of Gynecologic and Perinatal Endocrinology, Instituto Nacional de Perinatologia, Mexico City, Mexico.
Juan Mario Solis-ParedesDepartment of Human Genetics and Genomics, Instituto Nacional de Perinatologia, Mexico City, Mexico.
Salvador Espino Y SosaClinical Research Branch, Instituto Nacional de Perinatologia, Mexico City, Mexico.
Guadalupe Estrada-GutierrezResearch Direction, Instituto Nacional de Perinatologia, Mexico City, Mexico. gpestrad@gmail.com.ORCID 0000-0001-9551-9021
Instituto Nacional de Perinatología · MXInstituto Nacional de Pediatria · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maternal metabolic status influences pregnancy and, consequently, the perinatal outcome. Resistin is a pro-inflammatory adipokine predominantly expressed and secreted by mononuclear cells, adipose tissue, and placental trophoblastic cells during pregnancy. Recently, we reported an inverse association between maternal resistin levels and fetal low-density lipoprotein cholesterol (LDL-C). Then, in this work, we used a human placental explant model and the trophoblast cell line JEG-3 to evaluate whether resistin affects placental LDL-C uptake. Resistin exposure induced the transcription factor SREBP-2, LDLR, and PCSK9 mRNA expression, and changes at the protein level were confirmed by immunohistochemistry and Western blot. However, for LDLR, the changes were not consistent between mRNA and protein levels. Using a labeled LDL-cholesterol (BODIPY FL LDL), uptake assay demonstrated that the LDL-C was significantly decreased in placental explants exposed to a high dose of resistin and a lesser extent in JEG-3 cells. In summary, resistin induces PCSK9 expression in placental explants and JEG-3 cells, which could be related to negative regulation of the LDLR by lysosomal degradation. These findings suggest that resistin may significantly regulate the LDL-C uptake and transport from the maternal circulation to the fetus, affecting its growth and lipid profile.

Indexed as

Proprotein Convertase 9Receptors, LDLCell Line, TumorCholesterol, LDLFemaleHumansPlacentaPregnancyResistinRNA, MessengerCholesterol, LDLPCSK9 protein, humanProprotein Convertase 9Receptors, LDLResistinRNA, MessengerLDLRPlacentaPregnancyResistin

Identifiers

PMID35467263
PMCPMC9646615
OpenAlexW4224493758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.